Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baheal Medical
Qingdao, Shandong, Chinabaheal.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Baheal Medical has successfully launched a variety of innovative products with proprietary intellectual property rights. Its portfolio includes modern TCMs, extended-release chemical medicines, OTC/general health products, OTX/prescription medicines, oncology drugs, and high-end medical devices. Key commercialized examples include Fuzheng Huayu Tablet/Capsule for hepatitis B-related liver fibrosis and Nida® metformin hydrochloride sustained-release tablets for type 2 diabetes. Clinical results are not detailed publicly.
- Therapeutic areas
- Metabolic DisordersGastroenterologyEndocrinology
- Modalities
- Small moleculeTraditional Chinese medicine (TCM)Extended release oral solid dosage (OSD) formulationsChemical medicine
- Industry
- Biotech
Beyond the preview
Go deeper on Baheal Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baheal Medical.